{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-010503","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2023-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.925286+00:00","generated_at":"2026-06-19T16:04:57.419759+00:00","sec_items":["1.01","5.03","2.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Avalon GloboCare acquires 40% of Laboratory Services MSO for $21M","bullets":["Total consideration $21M: $9M cash, $11M in Series B Convertible Preferred stock (11,000 shares at $1,000 stated value), plus $1M anniversary payment due Feb 9, 2024.","Seller eligible for earnout up to $10M, with up to $5M cash and $5M in common stock based on Dec 31, 2023 closing price.","Buyer has option to purchase additional 20% of Lab Services MSO within 9 months for $6M cash + $4M in Series B preferred stock.","Series B Preferred converts to common at $3.78/share, subject to one-year lock-up period and monthly 10% resale limit thereafter.","Sarah Cox retained as consultant; Meng Li continues as COO and board member."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-010503","json":"https://secwatch.observer/filing/0001213900-23-010503.json","markdown":"https://secwatch.observer/filing/0001213900-23-010503.md","text":"https://secwatch.observer/filing/0001213900-23-010503.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023010503/0001213900-23-010503-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023010503/ea173222-8k_avalonglobo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T16:04:57.419759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86850f5103daa78e0608f9e9e7b852b73b861e7c","claim":"Avalon GloboCare Corp. completed an acquisition involving SCBC Holdings LLC for $21,000,000 (closed 2023-02-09).","evidence_excerpt":"Services MSO (the “ Purchased Interests ”), free and clear of all liens (the “ Transaction ”). The consideration paid by Buyer to Seller for the Purchased Interests consisted of $21,000,000, which comprised of (i) $9,000,000 in cash, (ii) $11,000,000 pursuant to the issuance of 11,000 shares of the Company’s newly designated Series B Convertible Preferred Stock (the “","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023010503/0001213900-23-010503-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"SCBC Holdings LLC"},{"label":"Consideration","value":"$21,000,000"},{"label":"Closing","value":"2023-02-09"}],"fact_type":"ma_transaction"},{"claim_id":"f405be70bf3ffbc164b4f9b77686ac61e63b4ce3","claim":"Avalon GloboCare Corp. entered into Amended MIPA with Seller.","evidence_excerpt":"he Series B Preferred Stock to the Seller, the terms of which are set forth below. The Company designated up to 15,000 shares of the","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023010503/0001213900-23-010503-index.htm","confidence":0.4,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Seller"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}